Anteris Technologies Ltd (AVR:ASX)

$7.11

right-arrow Created with Sketch. -0.11 (-1.52%)
MCAP $46.70M
Last trade 16.10pm 26/02/2021 20mins delayed

Latest Announcements

25/02/2021AVRAnteris Technologies Ltd
18/02/2021 Price SensitivePSAVRAnteris Technologies Ltd
18/02/2021 Price SensitivePSAVRAnteris Technologies Ltd
17/02/2021AVRAnteris Technologies Ltd
22/01/2021 Price SensitivePSAVRAnteris Technologies Ltd
22/01/2021AVRAnteris Technologies Ltd
20/01/2021AVRAnteris Technologies Ltd
20/01/2021AVRAnteris Technologies Ltd

Company Overview

Anteris Technologies Ltd, formerly Admedus Ltd, is an Australia-based structural heart company. The Company provides solutions for heart valves. Its products include ADAPT and DurAVR. ADAPT its anti-calcification treatment platform technology on which its structural heart products are developed. DurAVR, built with ADAPT technology, is a durable three dimension (3D) single-piece aortic valve for the treatment of aortic stenosis. Its DurAVR Development Portfolio includes DurAVR Leaflet Repair (RP), DurAVR Transcatheter Heart Valve (THV) and DurAVR Surgical Heart Valve (SHV).

AVR in the news

Search Previous Announcements